Exact Sciences

1. Patient uses Cologuard test at home.

2. Sample is sent to Exact Sciences' lab.

3. Lab analyzes the sample for cancer-related DNA markers.

4. Results are reported to the healthcare provider.

5. Positive results lead to further diagnostic evaluation (colonoscopy).

1. Oncotype DX test is ordered after breast cancer diagnosis.

2. Tumor sample is sent to Exact Sciences' lab.

3. Lab analyzes the sample for genomic alterations.

4. Recurrence Score is generated, predicting the likelihood of chemotherapy benefit.

5. Healthcare provider uses the score to make informed treatment decisions.

1. Patient undergoes genetic testing for hereditary cancer genes.

2. Sample is sent to Exact Sciences' lab.

3. Lab analyzes the sample for mutations in cancer-related genes.

4. Results are reported to the healthcare provider.

5. Positive results lead to increased surveillance and preventive measures.

1. ctDNA analysis is performed during and after treatment.

2. Samples are sent to Exact Sciences' lab.

3. Lab monitors ctDNA levels to assess treatment response.

4. Results are used to adjust treatment strategies as needed.

5. MRD monitoring helps detect early signs of relapse.

1. Tumor sample undergoes comprehensive genomic profiling.

2. Sample is sent to Exact Sciences' lab.

3. Lab identifies actionable mutations and potential targeted therapies.

4. Results are reported to the healthcare provider.

5. Targeted therapies are prescribed based on genomic findings.